Xencor | XNCR - Trade Creditors


Xencor reported $9.08M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
AbbVie USD 32.25B 1.2B Jun/2025
Alnylam Pharmaceuticals USD 117.59M 15.2M Sep/2025
Amgen USD 19.64B 1.61B Sep/2025
Arrowhead Research USD 32.94M 15.26M Dec/2025
AstraZeneca USD 25.03B 1.04B Sep/2025
Biogen USD 413.1M 4.7M Sep/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Cytokinetics USD 22.08M 46.46M Sep/2025
GlaxoSmithKline GBP 15.38B 294M Dec/2025
J&J USD 9.62B 161M Sep/2025
MacroGenics USD 5.94M 1.28M Sep/2025
Merck USD 4.15B 102M Sep/2025
Novartis USD 4.56B 49M Sep/2025
Pfizer USD 5.02B 142M Sep/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Xencor USD 9.08M 9.45M Sep/2025